Direct cardiac and vascular actions of adrenomedullin in conscious sheep

Por Parkes, David G, May, Clive N
Publicado em 1997

GLP-1R and amylin agonism in metabolic disease: complementary mechanisms and future opportunities

Por Roth, Jonathan D, Erickson, Mary R, Chen, Steve, Parkes, David G
Publicado em 2012

The exenatide analogue AC3174 attenuates hypertension, insulin resistance, and renal dysfunction in Dahl salt-sensitive rats

Por Fernandez Rayne, Broyde Anatoly, Adams Lisa, Liu Que, Baron Alain D, Parkes David G
Publicado em 2010-08-01

The exenatide analogue AC3174 attenuates hypertension, insulin resistance, and renal dysfunction in Dahl salt-sensitive rats

Por Liu, Que, Adams, Lisa, Broyde, Anatoly, Fernandez, Rayne, Baron, Alain D, Parkes, David G
Publicado em 2010

Glucagon-like peptide-1 and the exenatide analogue AC3174 improve cardiac function, cardiac remodeling, and survival in rats with chronic heart failure

Por Polizzi Clara, Broyde Anatoly, Anderson Christen, Liu Que, Fernandez Rayne, Baron Alain, Parkes David G
Publicado em 2010-11-01

Glucagon-like peptide-1 and the exenatide analogue AC3174 improve cardiac function, cardiac remodeling, and survival in rats with chronic heart failure

Por Liu, Que, Anderson, Christen, Broyde, Anatoly, Polizzi, Clara, Fernandez, Rayne, Baron, Alain, Parkes, David G
Publicado em 2010

Leptin responsiveness restored by amylin agonism in diet-induced obesity: Evidence from nonclinical and clinical studies

Por Roth, Jonathan D., Roland, Barbara L., Cole, Rebecca L., Trevaskis, James L., Weyer, Christian, Koda, Joy E., Anderson, Christen M., Parkes, David G., Baron, Alain D.
Publicado em 2008

Exenatide does not evoke pancreatitis and attenuates chemically induced pancreatitis in normal and diabetic rodents

Por Tatarkiewicz, Krystyna, Smith, Pamela A., Sablan, Emmanuel J., Polizzi, Clara J., Aumann, Donald E., Villescaz, Christiane, Hargrove, Diane M., Gedulin, Bronislava R., Lu, Melissa G. W., Adams, Lisa, Whisenant, Tina, Roy, Denis, Parkes, David G.
Publicado em 2010

Novel Exenatide Analogs with Peptidic Albumin Binding Domains: Potent Anti-Diabetic Agents with Extended Duration of Action

Por Levy, Odile E., Jodka, Carolyn M., Ren, Shijun Steven, Mamedova, Lala, Sharma, Abhinandini, Samant, Manoj, D’Souza, Lawrence J., Soares, Christopher J., Yuskin, Diane R., Jin, Li Jenny, Parkes, David G., Tatarkiewicz, Krystyna, Ghosh, Soumitra S.
Publicado em 2014

Improved Glucose Control and Reduced Body Weight in Rodents with Dual Mechanism of Action Peptide Hybrids

Por Trevaskis, James L., Mack, Christine M., Sun, Chengzao, Soares, Christopher J., D’Souza, Lawrence J., Levy, Odile E., Lewis, Diane Y., Jodka, Carolyn M., Tatarkiewicz, Krystyna, Gedulin, Bronislava, Gupta, Swati, Wittmer, Carrie, Hanley, Michael, Forood, Bruce, Parkes, David G., Ghosh, Soumitra S.
Publicado em 2013